Overview
Scott Tykodi is an Oncologist in Seattle, Washington. Dr. Tykodi is highly rated in 10 conditions, according to our data. His top areas of expertise are Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Adult Soft Tissue Sarcoma, and Nephrectomy.
His clinical research consists of co-authoring 66 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- PPO
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
825 Eastlake Ave E, Seattle, WA 98109
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Rachel Loschiavo PA-C
Ajay Gopal is an Oncologist in Seattle, Washington. Dr. Gopal is highly rated in 23 conditions, according to our data. His top areas of expertise are Follicular Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, and B-Cell Lymphoma.
Swedish Cardiovascular RSRCH
John Pagel is an Oncologist in Seattle, Washington. Dr. Pagel is highly rated in 19 conditions, according to our data. His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Rachel Loschiavo PA-C
Petros Grivas is an Oncologist in Seattle, Washington. Dr. Grivas is highly rated in 9 conditions, according to our data. His top areas of expertise are Urothelial Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Endoscopy.
Frequently Asked Questions about Dr. Scott Tykodi
How do I make an appointment with Dr. Scott Tykodi?
You can book an appointment with Dr. Scott Tykodi by calling their office at 855-557-0555. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Scott Tykodi a top-rated expert for Renal Cell Carcinoma (RCC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Scott Tykodi is classified as an Elite expert for Renal Cell Carcinoma (RCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Scott Tykodi specialize in?
While Dr. Scott Tykodi is a Oncology, they have specific expertise in Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, and Chromophobe Renal Cell Carcinoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Scott Tykodi participate in research or clinical trials?
Yes. Dr. Scott Tykodi has published 66 articles and abstracts on conditions like Renal Cell Carcinoma (RCC). You can view a list of Dr. Scott Tykodi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Scott Tykodi accept my insurance?
Dr. Scott Tykodi accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 855-557-0555 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Renal Cell Carcinoma (RCC)Dr. Tykodi isElite. Learn about Renal Cell Carcinoma (RCC).
- Distinguished
- Adult Soft Tissue SarcomaDr. Tykodi isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- Chromophobe Renal Cell CarcinomaDr. Tykodi isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Tykodi isDistinguished. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Tykodi isDistinguished. Learn about Familial Wilms Tumor 2.
- Wilms TumorDr. Tykodi isDistinguished. Learn about Wilms Tumor.
- WT1-Related Wilms Tumor SyndromesDr. Tykodi isDistinguished. Learn about WT1-Related Wilms Tumor Syndromes.
- Advanced
- MelanomaDr. Tykodi isAdvanced. Learn about Melanoma.
- Posterior Fossa TumorDr. Tykodi isAdvanced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)
- Experienced
- Follicular Thyroid CancerDr. Tykodi isExperienced. Learn about Follicular Thyroid Cancer.
- Lung CancerDr. Tykodi isExperienced. Learn about Lung Cancer.
- Merkel Cell CarcinomaDr. Tykodi isExperienced. Learn about Merkel Cell Carcinoma.
- Metastatic Brain TumorDr. Tykodi isExperienced. Learn about Metastatic Brain Tumor.
- NephrectomyDr. Tykodi isExperienced. Learn about Nephrectomy.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Tykodi isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).